title: Hypereosinophilic syndrome: another face of janus?
authors.forename: Issa J
authors.initials: IJ
authors.lastname: Dahabreh
authors.forename: Stavroula
authors.initials: S
authors.lastname: Giannouli
authors.forename: Cristine
authors.initials: C
authors.lastname: Zoi
authors.forename: Katerina
authors.initials: K
authors.lastname: Zoi
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Loukopoulos
authors.forename: Michael
authors.initials: M
authors.lastname: Voulgarelis
mesh_terms: D000368:Aged; D002908:Chronic Disease; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D053614:Janus Kinase 2 / Q000235:genetics*; D017354:Point Mutation; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D020796:Receptor, Platelet-Derived Growth Factor alpha; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D006918:Hydroxyurea